Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Urethral Compression Device Treats Male Urinary Incontinence

By HospiMedica International staff writers
Posted on 31 Oct 2018
A novel penile cuff eliminates the urinary leakage, discomfort, and impaired blood flow associated with traditional penile clamps.

The Pacey MedTech (Vancouver, Canada) Cuff is a urethral control device (UCD) designed to compress the urethra, minimizing leakage. Functional components include a distributed-pressure fenestrated hood for placement on the dorsal side of the penis, with two arms separated by a notch that distribute pressure so that the venous and arterial blood flows are not compromised; an elongated urethral compression pad to distribute pressure along the ventral side of the penis, so that the urethra is compressed; and a Velcro strap that joins the two sides of the device scale to provide a comfortable custom fit.

The unique design compliments the male anatomy, since the major vein and artery lie on the dorsal topside, and the urethra lies on the ventral underside. By applying pressure to the length of the urethra, while protecting penile blood circulation, the UCD eliminates the risk of ischemic pain that follows indiscriminate clamping. The Pacey Cuff was made to be light, soft, and comfortable, ensuring patients can discretely wear it all day, continue to live a normal life, engage in regular activities, and reduce their dependency on absorption pads by up to 100%.

“We have created a new value, and we are going to have a great impact on the care of patients in a wide number of areas of injury, including for post-spinal injury patients, for post-prostatectomy patients, and for many others,” said Jack Pacey, MD, founder of Pacey MedTech, and inventor of the Pacey Cuff. “Our goal is to get you back to the regular life you love. We designed the Pacey Cuff to be small, lightweight, and discreet. This means you can wear it all day, whether it’s at work, for exercise, while driving, and even for swimming.”

Urinary incontinence can result from functional abnormalities of the bladder or urethra, particularly in men with prostate disease. Whilst not a life-threatening condition, it can have an enormous impact on quality of life, including severe embarrassment, restriction in daily activities and social life, as well as limiting the ability to work and travel. Urinary incontinence in men most commonly occurs as a result of treatment for prostate cancer. Treatment options include minimally invasive sling surgery, an artificial urinary sphincter, pads, clamps, and urethral bulking agents.

Related Links:
Pacey MedTech


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Needle-Free IV Connector Technology
Clave
New
Transportation Stretcher
ES709
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get complete access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The Trilogy Valve with locator technology is the only TAVI system approved for aortic regurgitation (Photo courtesy of JenaValve)

New Transcatheter Valve Found Safe and Effective for Treating Aortic Regurgitation

Aortic regurgitation is a condition in which the aortic valve does not close properly, allowing blood to flow backward into the left ventricle. This results in decreased blood flow from the heart to the... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.